Technology
Bioheart Inc. offers the Bioheart 3370 Heart Failure Monitor, an interactive and simple-to-use at-home device designed to better monitor patients outside hospitals who are suffering from heart failure. The device, manufactured by RTX Healthcare A/S of Denmark, has FDA 510(k) market clearance and CE Mark in Europe.
July 10, 2008
News
July 11, 2008 - Micrus Endovascular Corp. said this week it received approval from the Ministry of Health, Labour and Welfare (MHLW) to market in Japan the Cerecyte microcoil product line, including the MicruSphere, Presidio, HeliPaq and UltiPaq Cerecyte embolic coils, for the endovascular treatment of cerebral aneurysms.
July 10, 2008
Feature | Cristen Bolan
Cardiology fellows are expanding their knowledge in cardiovascular imaging. Not only do virtually all cardiology fellows get Level 2 training in echocardiography and many in nuclear cardiology but now, an increasing number of fellows are training in cardiac MR and cardiac CT.
July 09, 2008Sponsored Content
Feature | Nuclear Imaging
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
November 12, 2025News
July 10, 2008 - Boston Scientific Corp. this week launched its Atlantis .018 Peripheral Imaging Catheter, which reportedly brings existing 40 MHz coronary standard ultrasound imaging resolution to peripheral interventions. The company said the product is available for immediately release in the U.S.
July 09, 2008Feature | Cristen Bolan
What makes cardiologists more capable of reading cardiac imaging exams than other physicians such as radiologists, who ...
July 09, 2008
Feature | Stents | Ellen W. Rothschild, RN, MS
(Editor's note: this article was updated in March 2017 with links at the bottom to more current stent technology ...
July 09, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
July 10, 2008 - Datascope Corp. said today it exercised its option to acquire the Peripheral Vascular Stent business of ...
July 09, 2008
Feature | Archana Swathy, Research Analyst, Frost & Sullivan
Physicians recognize the importance of ventricular assist devices (VADs) every time a congestive heart failure (CHF) ...
July 09, 2008News
July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has ...
July 09, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Richard R. Rogoski
Preliminary results of a multicenter study show that the use of tiny clips to repair the mitral valve may someday ...
July 09, 2008News
July 10, 2008 - The Senate overcame partisan gridlock on July 9, 2008, and passed the Medicare Improvements for Patients ...
July 09, 2008
Feature | Nick Obradovich
The only safe assumption to make about today’s current gold standard imaging modality used to identify and evaluate atheromatous plaque in the peripheral arteries is that there is not one gold standard. To locate and evaluate these plaques that cause peripheral vascular disease (PVD), physicians have multiple tried-and-true imaging tests at their disposal.
July 09, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Maureen Leahy-Patano
Safe delivery of the balloon or stent through fragile vasculature during percutaneous transluminal coronary angioplasty (PTCA) procedures is an important criterion for successful patient outcomes.
July 09, 2008
Technology
The Abiomed Inc. Impella 2.5 cardiac assist device was FDA cleared in 2008 for use for partial circulatory support for periods up to six hours. The intra-aortic balloon pump (IABP) also has 510(k) clearance and approximately 110,000 are used each year in the U.S.
July 08, 2008Technology
The FloTrac is reportedly the first minimally invasive hemodynamic monitoring device that connects to any existing arterial line and requires no manual calibration. The latest enhancement to the FloTrac software empowers clinicians with greater flexibility to trend and analyze the patient parameters in order to make better informed decisions, said the company.
July 08, 2008